MAP3K14 and systemic lupus erythematosus: Since the crystal structure analysis of NIK was clarified (24, 25), selective inhibitors of NIK have been developed, and in addition to regulating cell proliferation and differentiation, they are effective against liver inflammation/steatosis, rheumatoid arthritis, lupus, osteoporosis, metabolic disorder, and cancer in animal models (26, 27).